1. Home
  2. UP vs IPHA Comparison

UP vs IPHA Comparison

Compare UP & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheels Up Experience Inc.

UP

Wheels Up Experience Inc.

HOLD

Current Price

$4.37

Market Cap

179.6M

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$2.06

Market Cap

165.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UP
IPHA
Founded
2013
1999
Country
United States
France
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.6M
165.3M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
UP
IPHA
Price
$4.37
$2.06
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
92.3K
175.2K
Earning Date
05-12-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$736,495,000.00
N/A
Revenue This Year
N/A
$180.36
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$1.18
52 Week High
$10.09
$2.71

Technical Indicators

Market Signals
Indicator
UP
IPHA
Relative Strength Index (RSI) 33.49 52.90
Support Level $0.49 $1.67
Resistance Level $5.40 $2.66
Average True Range (ATR) 0.27 0.09
MACD -0.00 -0.02
Stochastic Oscillator 23.14 41.73

Price Performance

Historical Comparison
UP
IPHA

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation. The company offers a private aviation solution with a large and diverse aircraft fleet, delivered through a mix of charter solutions and its membership program that utilizes its controlled aircraft fleet and a network of safety-vetted charter operators. Through its partnership firm, it provides members and customers with an offering across private and premium commercial travel. It generates the majority of its revenue from member and customer flights through its membership program and charter solutions, as well as from membership fees and other activities and services, including group charter flights, cargo flights, and special missions. Geographically, the company generates maximum revenue from the United States.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: